Johnson & Johnson
NYSE: JNJ
$164.11
-$0.71 (-0.4%)
Closing Price on September 20, 2024
JNJ Articles
With markets at all-time highs, it's important to consider the winners and losers. In this case, many stocks in the Dow are still holding the index back from even stronger gains.
Published:
Goldman Sachs may have the best strategy for investors for 2020. Here are five stocks that look like great ideas now for investors looking to mold such a plan.
Published:
Johnson & Johnson has found itself involved in more controversy than the company would prefer to see. But it seems that not even bad news lasts forever.
Published:
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Published:
Wednesday's top analyst upgrades, downgrades and initiations included Adobe, Alibaba, Amazon.com, AT&T, Comcast, Delphi Technologies, DocuSign, Johnson & Johnson, JPMorgan, T-Mobile, Verizon...
Published:
Johnson & Johnson reported better than expected quarterly results before the markets opened on Tuesday.
Published:
Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday, and analysts' expectations are mild overall.
Published:
Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.
Published:
Friday's top analyst upgrades, downgrades and initiations included Apple, Canopy Growth, CrowdStrike, Delta Air Lines, Johnson & Johnson, Rio Tinto, Roku, Square, Tilray and Twilio.
Published:
Johnson & Johnson shares dropped on Wednesday following the announcement that a jury has awarded $8 billion in damages to a man accusing the drugmaker of failing to warn about the side effects of...
Published:
One analyst issued a fairly bullish report in response to Johnson & Johnson's announcement of a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial.
Published:
Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy settlement by Purdue Pharmaceuticals and be released from liability in the...
Published:
The last thing investors want is a value trap loser that stays stagnant, but all these top companies have solid long-term prospects.
Published:
As, when and if ESG themes continue to gain in popularity, imagine what could happen to some of the top-ranked ESG companies. Imagine also what could happen to some of the companies that are...
Published:
Last Updated:
Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are taking it on the chin.
Published:
Last Updated: